HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as Preside... ( NEW YORK and PITTSBURGH Dec. 7 2011 /...)

HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO

Date:12/7/2011

NEW YORK and PITTSBURGH, Dec. 7, 2011 /PRNewswire/ -- HealthpointCapital, LLC ("HealthpointCapital") announced today the purchase of Blue Belt Technologies, Inc. ("Blue Belt" or "Company"). Blue Belt is developing the next generation of "smart" surgical instruments for use initially in orthopedic procedures and then for other surgical specialties including neurosurgery and otolaryngology ("ENT"). Terms of the transaction were not disclosed.

"Blue Belt is HealthpointCapital's first acquisition to create the worldwide leader in providing a continuum of care for patients suffering from orthopedic diseases," stated Mortimer Berkowitz III, President and Managing Director of HealthpointCapital. "Historically, patients with arthritic disorders have had limited treatment options. We will offer more treatments for patients throughout their disease – resulting in a broader continuum of care. Blue Belt's Navio PFS system is a perfect flagship technology to lead our investment strategy because of its superiority to currently marketed robotic systems."

HealthpointCapital also announced the appointment of Eric B. Timko as President and CEO of Blue Belt. Mr. Timko brings with him over 20 years of experience in the medical device industry and has a proven track record in commercializing medical technologies as well as building effective and profitable sales and distribution organizations. "I am excited to join Blue Belt at this crucial time as we enter into the commercialization phase of the Company. The significant research and development efforts of the Blue Belt team have resulted in the Navio PFS having many advantages over other systems available in the market, the most compelling being the small footprint and cost effectiveness of the system. We look forward to introducing our technology to physicians around the world."

Blue Belt Technologies, Inc.

Blue Belt Technologies, Inc. is developing the next generation of "smart" surg
'/>"/>

SOURCE HealthpointCapital, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Roche Acquires Verum Diagnostica GmbH as Part of Plan to Develop Comprehensive Coagulation Testing Portfolio for Diagnostic Laboratories
2. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
3. Ansell Limited Acquires a Minority Share in Yulex Corporation
4. Ancor Acquires WellSpring Pharmaceutical Corporation
5. WuXi PharmaTech Acquires China-Based Clinical Research Services Companies
6. Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals
7. AMETEK Acquires Reichert Technologies
8. Cynosure Acquires Worldwide Exclusive Rights to Distribute PinPointe™ FootLaser™ for Treatment of Onychomycosis
9. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
10. Ariel Pharmaceuticals, Inc. Acquires Novel Compound for Acute Migraine
11. ImpactRx Acquires TargetRx

Post Your Comments:

(Date:6/18/2013)... -- New-generation electronic designs are focused on rugged ... circuitry is increasing the number of functions it ... performs at. Connecting cables from the active elements ... as cameras or detectors, must be small, flexible ... custom cable designs for high-quality signal and EMI ...

(Date:6/18/2013)... And EMERYVILLE, Calif. , June ... final results today from a Phase 2/3 clinical ... demonstrating a statistically significant improvement in levodopa-induced dyskinesia ... week 8 versus placebo in the Unified Dyskinesia ... formulation of amantadine intended for once-nightly administration that ...

(Date:6/18/2013)... 18, 2013 Polymer Technology Systems, Inc. ... Health Group to integrate the CardioChek ® ... administered by health systems across the country. The ... and distributed through Hanson Medical Systems , ... cholesterol, LDL cholesterol, triglycerides, and glucose. ...

Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3

[0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease [0] Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients

... WOODLANDS, Texas, Aug. 10, 2011 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... trial of LX1031 in patients with non-constipating ... in the August 2011 edition of the journal ...

... Environmental testing and monitoring programs are essential ... understand industrial sterilization and contamination control procedures to bring ... In attempting to meet regulatory demands from ... Pharmacopoeia, the greatest challenge for medical device and pharmaceutical ...

Cached Medicine Technology:Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology 2 Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology 3 "Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers" - New White Paper from Microtest Laboratories 2

Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology "Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers" - New White Paper from Microtest Laboratories

(Date:6/19/2013)... CO (PRWEB) June 19, 2013 ... marketing company for coaches, announced today its affiliation ... means CoachingWebsites will offer exclusive websites and marketing ... partnerships. , “This new partnership with Active Intelligence ... their business to its fullest,” says Greer Van ...

(Date:6/19/2013)... 2013 The Mesothelioma Victims Center ... of the 2500 to 3000 citizens, who will be ... this year, about one third will be US Navy ... with this asbestos exposure form of cancer, or their ... to the nations most skilled mesothelioma compensation settlement attorneys, ...

(Date:6/19/2013)... Middle market merger and acquisition (M&A) activity ... cash rich buyers seek to place their capital in ... transactions have a good deal in common. The acquirer ... and quality of the target company’s earnings. Potential risks ... diligence involves a middle market company, whose value consists ...

(Date:6/18/2013)... 19, 2013 oBand Surgery Centers, a ... holding complimentary weight loss seminars in Los Angeles this ... be accessed at their official website. oBand Surgery Centers ... time. Their highly skilled panel of surgeons and dedicated ... , A senior executive working with oBand Surgery Centers ...

(Date:6/18/2013)... Philadelphia, PA, June 19, 2013 Recent studies ... coverage of bullying-related suicide among young people, led ... to assemble an expert panel to focus on ... about the complex relationship between youth involvement in ... Bullying among youth is a significant public health ...

Breaking Medicine News(10 mins):Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2 Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2 Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3 Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2 Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3 Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2 Health News:Bullying and suicide among youth is a public health problem 2

[0] CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC [0] Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation [0] Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company [0] oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June [0] Bullying and suicide among youth is a public health problem

... May 11 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... worldwide announced today its selected unaudited,financial results for the first ... Highlights for First Quarter 2009, -- First ... 53.5% over the first ...

... Trust Incorporated (NYSE: HR ) today announced its ... 2009. This dividend, in the amount of $0.385 per ... record on May 22, 2009. The total dividend of ... operations determined in accordance with GAAP. The Company,s cash ...

... Health Care Costs Over Next Ten Years, Provides Significant ... Year WASHINGTON, May 11 Today, key stakeholders in ... House to announce their commitment to achieving a sharp ... to prioritize preventive care, manage chronic illnesses, curtail unnecessary ...

... will be lethality of infection going forward, experts say , , ... epidemic does have pandemic potential and is likely to be ... of its spread, a new expert analysis concludes. , The ... unreported -- swine flu infections in Mexico, the outbreak,s epicenter, ...

... Call on May 14, 2009 NEW HAVEN, Conn., May 11 ... announced financial results for the first quarter of 2009. , ... $4.3 million, or $0.54 per share, for the quarter ended March ... $1.14 per share, for the same 2008 period. Weighted-average common ...

... prominently featured on the HRS 2009 programST. LOUIS, May ... said today that the Heart Rhythm 2009 formal program ... Niobe system is either featured or discussed regarding the ... efficacy data on the use of Stereotaxis, partnered magnetic ...

Mindray Announces First Quarter 2009 Financial Results Healthcare Realty Trust Announces First Quarter Dividend Kaine Lauds President Obama's Agreement With Health Care Industry Groups to Reduce Health Care Costs Study Supports Swine Flu's Pandemic Potential Vion Pharmaceuticals Reports 2009 First Quarter Results Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009

Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....

VascoStim 2F are bipolar temporary pacing leads to be used in conjunction with thermodilution catheters with implemented paceport-channel....

The Aescula LV left-heart lead is a stylet-driven, silicone insulated lead with a titanium nitride (TiN) coated platinum-iridium electrode....

Medicine Products:

VascoStim 2/5F J VascoStim 2/5F S VascoStim 2F Aescula LV Left-Heart Lead